Valrubicin Intravesical Solution Solution, Concentrate
Product Images NDC 24201-101

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valrubicin Intravesical Solution (NDC 24201-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Chemical Structure Of Valrubicin (Val 1)

Chemical structure of valrubicin, the active ingredient in Valrubicin Intravesical Solution 40 mg/mL, showing its molecular configuration with multiple ring systems and functional groups.*

FDA Label Image

Figure 2. Comparison Of Mean Auc0-6 Hours In Valrubicin Intravesical Solution Clinical Studies (n=number Of Patients) (Val 2)

A bar chart titled 'Comparison of Mean AUC Values 0-6 Hours in Valrubicin Intravesical Solution Clinical Studies' showing total serum anthracyclines (pmoles/L-hr) across five clinical study patient subsets. The subsets include 'Two Weeks After TUR 900 mg', 'Typical TUR 800 mg', 'Extensive TUR 800 mg', 'Perforated Bladder 800 mg', and 'IV Infusion 600 mg/m2', with varying measured values displayed by vertical bars.*

FDA Label Image

Vial Label (Val 3)

The label for Valrubicin Intravesical Solution USP 200 mg/5 mL (40 mg/mL) by Hikma Pharmaceuticals USA Inc. It is a cytotoxic agent for intravesical use only, supplied as a 5 mL single-dose vial. The label includes cautions, storage instructions at 2 to 8°C, preservative information, and barcodes. The product is made in the USA.*

FDA Label Image

Carton Image (Val 4)

Packaging label for Valrubicin Intravesical Solution, USP 200 mg/5 mL (40 mg/mL) concentrate, for intravesical use only. The label includes usage warnings, a barcode, and the caution notice 'Cytotoxic Agent.' It specifies 4 vials of 5 mL each, manufactured for Leucadia Pharmaceuticals and labeled with NDC 24201-101-04.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.